{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:51:21Z","timestamp":1787241081812,"version":"build-2736575974"},"reference-count":49,"publisher":"Elsevier BV","issue":"40","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Korea Ministry of Trade, Industry & Energy, South Korea","award":["10067809"],"award-info":[{"award-number":["10067809"]}]},{"name":"Korea Ministry of Health and Welfare, South Korea"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.vaccine.2019.08.036","type":"journal-article","created":{"date-parts":[[2019,8,26]],"date-time":"2019-08-26T07:53:50Z","timestamp":1566806030000},"page":"5954-5961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Skin immunization with third-generation hepatitis B surface antigen using microneedles"],"prefix":"10.1016","volume":"37","author":[{"given":"Thuy Trang","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-ah","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji Seok","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eunji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Won Jun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seung-Ki","family":"Baek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manki","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Hwan","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2019.08.036_b0005","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jhep.2009.01.002","article-title":"Hepatitis B vaccination: the key towards elimination and eradication of hepatitis B","volume":"50","author":"Chen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0010","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1056\/NEJM198010093031501","article-title":"Hepatitis B vaccine","volume":"303","author":"Szmuness","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.08.036_b0015","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/307178a0","article-title":"Human hepatitis B vaccine from recombinant yeast","volume":"307","author":"McAleer","year":"1984","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2019.08.036_b0020","doi-asserted-by":"crossref","first-page":"6266","DOI":"10.1016\/j.vaccine.2008.09.056","article-title":"The global impact of vaccination against hepatitis B: a historical overview","volume":"26","author":"Zanetti","year":"2008","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2019.08.036_b0025","first-page":"106","article-title":"Non-responders to hepatitis B vaccination: a review","volume":"6","author":"Kubba","year":"2003","journal-title":"Commun Dis Public Health"},{"key":"10.1016\/j.vaccine.2019.08.036_b0030","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.vaccine.2014.02.072","article-title":"Immune response to hepatitis B vaccination in drug using populations: a systematic review and meta-regression analysis","volume":"32","author":"Kamath","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.036_b0035","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJM198909143211103","article-title":"Genetic prediction of nonresponse to hepatitis B vaccine","volume":"321","author":"Alper","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2019.08.036_b0040","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jhep.2014.04.041","article-title":"Hepatitis B virus PreS\/S gene variants: pathobiology and clinical implications","volume":"61","author":"Pollicino","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0045","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/0264-410X(94)90155-4","article-title":"Improved immunogenicity in mice of a mammalian cell-derived recombinant hepatitis B vaccine containing pre-S1 and pre-S2 antigens as compared with conventional yeast-derived vaccines","volume":"12","author":"Shouval","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.036_b0050","doi-asserted-by":"crossref","first-page":"9174","DOI":"10.1073\/pnas.83.23.9174","article-title":"A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees","volume":"83","author":"Itoh","year":"1986","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.vaccine.2019.08.036_b0055","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1002\/jmv.20524","article-title":"Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines","volume":"78","author":"Zuckerman","year":"2006","journal-title":"J Med Virol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0060","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00430-014-0374-x","article-title":"Enhanced immune response to hepatitis B vaccination through immunization with a Pre-S1\/Pre-S2\/S vaccine","volume":"204","author":"Shouval","year":"2015","journal-title":"Med Microbiol Immunol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0065","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1128\/CVI.05355-11","article-title":"Use of pre-S protein-containing hepatitis B virus surface antigens and a powerful adjuvant to develop an immune therapy for chronic hepatitis B virus infection","volume":"19","author":"Yum","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0070","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nri3646","article-title":"Mechanisms regulating skin immunity and inflammation","volume":"14","author":"Pasparakis","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0075","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nri1310","article-title":"Immune surveillance in the skin: mechanisms and clinical consequences","volume":"4","author":"Kupper","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0080","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1038\/nri2358","article-title":"Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases","volume":"8","author":"Gilliet","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0085","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1086\/501756","article-title":"Comparison of higher-dose intradermal hepatitis B vaccination to standard intramuscular vaccination of healthcare workers","volume":"21","author":"Henderson","year":"2000","journal-title":"Infect Control Hosp Epidemiol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0090","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/j.1365-2893.2010.01354.x","article-title":"Intradermal vs intramuscular vaccine against hepatitis B infection in dialysis patients: a meta-analysis of randomized trials","volume":"18","author":"Fabrizi","year":"2011","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.vaccine.2019.08.036_b0095","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10620-011-1996-0","article-title":"Efficacy of high-dose intra-dermal hepatitis B virus vaccine in previous vaccination non-responders with chronic liver disease","volume":"57","author":"Dhillon","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.vaccine.2019.08.036_b0100","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.3748\/wjg.v18.i40.5729","article-title":"Intramuscular vs intradermal route for hepatitis B booster vaccine in celiac children","volume":"18","author":"Leonardi","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0105","doi-asserted-by":"crossref","first-page":"1600750","DOI":"10.1002\/adhm.201600750","article-title":"Ebola vaccination using a DNA vaccine coated on PLGA-PLL\/\u03b3PGA nanoparticles administered using a microneedle patch","volume":"6","author":"Yang","year":"2017","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.vaccine.2019.08.036_b0110","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1002\/adhm.201300006","article-title":"Host responses in human skin after conventional intradermal injection or microneedle administration of virus-like-particle influenza vaccine","volume":"2","author":"Pearton","year":"2013","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.vaccine.2019.08.036_b0115","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ijpharm.2018.07.049","article-title":"Design and characterisation of a dissolving microneedle patch for intradermal vaccination with heat-inactivated bacteria: a proof of concept study","volume":"549","author":"Rodgers","year":"2018","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2019.08.036_b0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jconrel.2016.06.045","article-title":"Influenza nucleoprotein DNA vaccination by a skin targeted, dry coated, densely packed microprojection array (Nanopatch) induces potent antibody and CD8+ T cell responses","volume":"237","author":"Fernando","year":"2016","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2019.08.036_b0125","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jconrel.2017.04.027","article-title":"Effective humoral immune response from a H1N1 DNA vaccine delivered to the skin by microneedles coated with PLGA-based cationic nanoparticles","volume":"265","author":"Seok","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2019.08.036_b0130","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.07.017","article-title":"Diphtheria toxoid and N-trimethyl chitosan layer-by-layer coated pH-sensitive microneedles induce potent immune responses upon dermal vaccination in mice","volume":"262","author":"Schipper","year":"2017","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2019.08.036_b0135","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.biomaterials.2017.08.038","article-title":"Hepatitis B surface antigen incorporated in dissolvable microneedle array patch is antigenic and thermostable","volume":"145","author":"Poirier","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2019.08.036_b0140","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ijpharm.2017.08.110","article-title":"Development of novel double-decker microneedle patches for transcutaneous vaccine delivery","volume":"532","author":"Ono","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.vaccine.2019.08.036_b0145","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1007\/s11095-015-1833-9","article-title":"Enhanced stability of inactivated influenza vaccine encapsulated in dissolving microneedle patches","volume":"33","author":"Chu","year":"2016","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2019.08.036_b0150","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1002\/btm2.10098","article-title":"Hepatitis B vaccination using a dissolvable microneedle patch is immunogenic in mice and rhesus macaques","volume":"3","author":"Perez Cuevas","year":"2018","journal-title":"Bioeng Transl Med"},{"key":"10.1016\/j.vaccine.2019.08.036_b0155","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4161\/hv.34299","article-title":"Tailored immunity by skin antigen-presenting cells","volume":"11","author":"Levin","year":"2014","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2019.08.036_b0160","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s11095-016-2042-x","article-title":"Bleomycin-coated microneedles for treatment of warts","volume":"34","author":"Lee","year":"2017","journal-title":"Pharm Res"},{"key":"10.1016\/j.vaccine.2019.08.036_b0165","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s13346-014-0211-1","article-title":"Considerations in the sterile manufacture of polymeric microneedle arrays","volume":"5","author":"McCrudden","year":"2015","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.vaccine.2019.08.036_b0170","doi-asserted-by":"crossref","first-page":"3756","DOI":"10.1016\/j.biomaterials.2012.01.054","article-title":"Stability of influenza vaccine coated onto microneedles","volume":"33","author":"Choi","year":"2012","journal-title":"Biomaterials"},{"key":"10.1016\/j.vaccine.2019.08.036_b0175","doi-asserted-by":"crossref","first-page":"e7152","DOI":"10.1371\/journal.pone.0007152","article-title":"Stabilization of influenza vaccine enhances protection by microneedle delivery in the mouse skin","volume":"4","author":"Quan","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.08.036_b0180","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s10544-013-9799-z","article-title":"Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays","volume":"15","author":"Guo","year":"2013","journal-title":"Biomed Microdevices"},{"key":"10.1016\/j.vaccine.2019.08.036_b0185","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.jconrel.2010.06.028","article-title":"Bioneedles as alternative delivery system for hepatitis B vaccine","volume":"147","author":"Hirschberg","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2019.08.036_b0190","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jconrel.2009.10.013","article-title":"Formulation and coating of microneedles with inactivated influenza virus to improve vaccine stability and immunogenicity","volume":"142","author":"Kim","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.vaccine.2019.08.036_b0195","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1208\/s12249-010-9471-3","article-title":"Formulation of microneedles coated with influenza virus-like particle vaccine","volume":"11","author":"Kim","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.vaccine.2019.08.036_b0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/bj2420001","article-title":"Stabilization of dry phospholipid bilayers and proteins by sugars","volume":"242","author":"Crowe","year":"1987","journal-title":"Biochem J"},{"key":"10.1016\/j.vaccine.2019.08.036_b0205","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1016\/S0264-410X(01)00063-9","article-title":"Storage at \u22123\u00b0C for 24 h alters the immunogenicity of pertussis vaccines","volume":"19","author":"Boros","year":"2001","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.vaccine.2019.08.036_b0210","first-page":"101","article-title":"Effects of freezing on DPT and DPT-IPV vaccines, absorbed","volume":"21","author":"Dimayuga","year":"1995","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2019.08.036_b0215","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0264-410X(99)00149-8","article-title":"Physical, chemical and immunological stability of CHO-derived hepatitis B surface antigen (HBsAg) particles","volume":"18","author":"Diminsky","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2019.08.036_b0220","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s13346-016-0282-2","article-title":"Long-term stability of influenza vaccine in a dissolving microneedle patch","volume":"7","author":"Mistilis","year":"2017","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.vaccine.2019.08.036_b0225","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.3107127","article-title":"Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production","volume":"236","author":"Snapper","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2019.08.036_b0230","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0065-2776(08)60536-2","article-title":"Mechanism and regulation of Immunoglobulin Isotype Switching54 (1993)","volume":"54","author":"Coffman","year":"1993","journal-title":"Adv Immunol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004773","article-title":"Transdermal influenza immunization with vaccine-coated microneedle arrays","volume":"4","author":"Koutsonanos","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.vaccine.2019.08.036_b0240","doi-asserted-by":"crossref","first-page":"pp. 1676-","DOI":"10.3389\/fimmu.2017.01676","article-title":"Langerhans cells-programmed by the epidermis","volume":"8","author":"Clayton","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2019.08.036_b0245","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3904\/kjim.2016.227","article-title":"Fundamental role of dendritic cells in inducing Th2 responses","volume":"33","author":"Kim","year":"2018","journal-title":"Korean J Intern Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X19311004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T18:50:55Z","timestamp":1567623055000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X19311004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":49,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S0264410X19311004"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.036","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skin immunization with third-generation hepatitis B surface antigen using microneedles","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2019.08.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}